Build with KISHO Sign In Sign Up

Kisho

Shire Laboratories Inc. — Rare Disease Pipeline | Kisho | Kisho

Shire Laboratories Inc.

Other

3

Orphan Designations

0

FDA Approvals

12

Rare Diseases

0

News Articles

Disease	Drug(s)	Designation	Approved
Wolf-Hirschhorn syndrome	Butyrylcholinesterase	Orphan Designation	-
autoimmune disorder of the nervous system	Butyrylcholinesterase	Orphan Designation	-
ciliary dyskinesia, primary, 41	Butyrylcholinesterase	Orphan Designation	-
ciliary dyskinesia, primary, 47, and lissencephaly	Butyrylcholinesterase	Orphan Designation	-
congenital arteriovenous fistula	Allogeneic human aortic endothelial cells cultured in a porcine gelatin matrix	Orphan Designation	-
congenital systemic arteriovenous fistula	Allogeneic human aortic endothelial cells cultured in a porcine gelatin matrix	Orphan Designation	-
dural sinus malformation	Allogeneic human aortic endothelial cells cultured in a porcine gelatin matrix	Orphan Designation	-
post-surgical hypoinsulinemia	Butyrylcholinesterase	Orphan Designation	-
post-traumatic stress disorder	Butyrylcholinesterase	Orphan Designation	-
postsurgical hypothyroidism	Butyrylcholinesterase	Orphan Designation	-
primary ciliary dyskinesia 18	Butyrylcholinesterase	Orphan Designation	-
primary ciliary dyskinesia 28	Butyrylcholinesterase	Orphan Designation	-

← Back to Companies